ArticleInfection and drug resistance2020
Molecular Characterization of Carbapenem-Resistant
Article in Infection and drug resistance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 29 citations in OpenAlex.
- Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026Review
- Interplay between porin deficiency, fitness, and virulence in carbapenem-non-susceptible Pseudomonas aeruginosa and Enterobacteriaceae.PLoS pathogens · 2025Review
- Global genomic epidemiology and plasmid-mediated dissemination ofCurrent research in microbial sciences · 2025Article
- Detection of clinicalHeliyon · 2024Article
- A preliminary exploration on the mechanism of the carbapenem-resistance transformation of Serratia marcescens in vivo.BMC genomics · 2024Article
- First report of coexistence of blaKPC-2 and blaNDM-1 in carbapenem-resistant clinical isolates ofFrontiers in microbiology · 2024Article
- Article
- The genomic characterization of carbapenem-resistantJAC-antimicrobial resistance · 2023Article
- Genomic characterization of two carbapenem-resistantFrontiers in cellular and infection microbiology · 2023Article
- Development and Evaluation of a Core Genome Multilocus Sequencing Typing (cgMLST) Scheme for Serratia marcescens Molecular Surveillance and Outbreak Investigations.Journal of clinical microbiology · 2022Article
- Analysis of the molecular characteristics of a blaKPC-2-harbouring untypeable plasmid in Serratia marcescens.International microbiology : the official journal of the Spanish Society for Microbiology · 2022Article
- Molecular Characterization of Carbapenem-ResistantInfection and drug resistance · 2022Article
- Third-Generation Cephalosporin Resistance in Intrinsic Colistin-Resistant Enterobacterales Isolated from Retail Meat.Antibiotics (Basel, Switzerland) · 2021Article
- Clinical and Microbiological Characteristics of a Community-Acquired Carbapenem-ResistantFrontiers in medicine · 2021Article
- Metallo-β-Lactamase and Extended-Spectrum-β-Lactamase Production byInfection and drug resistance · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAlthough carbapenem-resistant Enterobacteriaceae (CRE) have been thoroughly investigated as the pathogens most commonly associated with clinical infections, data on
methodsIn this study, we characterized 36 carbapenem-resistant
resultsThirty-three of the 36 isolates showed carbapenem resistance conferred by a
conclusionThe thirty-six CRSM isolates were mainly clonally disseminated with a
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.